Synthetic drugs (medicinal chemistry): Science
Principles
The science it rests on, with why each principle matters to it
Relies on- Structural theory of organic chemistry Knowing how atoms are joined in a molecule lets chemists change one part on purpose, as when salicylic acid was acetylated to make aspirin [1].
- Receptor theory of drug action Drugs act on specific receptive substances on cells, an idea Langley set out from 1907 [4].
as of 2026-11-10
Discoveries
The discoveries that made it possible: when, by whom and what was found
| Year | Who | What |
|---|---|---|
| 1853 | Charles Frédéric Gerhardt, Strasbourg | First synthesis of acetylsalicylic acid, in impure form [1] |
| 1907 | John Newport Langley | Cells carry specific receptive substances through which drugs and hormones act [4] |
| 1932 | Gerhard Domagk and colleagues | A made chemical, a sulfonamide, can counter the bacteria that cause blood poisoning in mice [3] |
as of 2026-11-10
The science explained
The science behind it explained for a curious reader
Think of a cell as covered in locks. Each lock, a receptor, opens a particular response when the right key, a hormone or nerve signal, slots in. Langley argued from 1907 that cells carry such specific receptive substances [4]. A drug is a key made by chemists. Some keys open the lock and copy the body's own signal; others jam it and block the signal. The fit depends on the shape of the molecule and where its charges sit, so changing a single group of atoms can turn a weak drug into a strong one, or a toxic one into a safe one. That is the craft of medicinal chemistry: making many slightly different keys and testing which works best, as Ehrlich's team did on the way to compound 606 [2].
as of 2026-11-10
Sources
- Aspirin (Brands with history) German Patent and Trade Mark Office (DPMA)
- Early Solution Science History Institute, Distillations (Gigi Naglak and Rosie Cook), 2012
- Gerhard Domagk: Facts Nobel Prize Outreach (NobelPrize.org)
- John Newport Langley, FRS Trinity College, Cambridge